Who owns Scpharmaceuticals Inc?

Tip: Access positions for across all investors

Analyze quarterly positions in Scpharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Scpharmaceuticals stock

Who bought or sold Scpharmaceuticals Inc this quarter?

There are no current stakeholders of Scpharmaceuticals.

This is normal when the security:

  • Has been acquired or taken private
  • Has merged with another entity
  • Has changed its name and has a new CUSIP (and/or symbol)
  • Has been delisted and the ticker has changed

Please use Search to find the security you were looking for.

Who sold out of Scpharmaceuticals?

Fund or Company Name Date Sold Shares Held Valued At
Vanguard Group Sep 2025 2.2M $12M
State Street Corporation Sep 2025 849k $4.8M
Royal Bank of Canada Sep 2025 500k $2.2M
Diadema Partners Sep 2025 462k $2.6M
Apis Capital Advisors Sep 2025 440k $2.5M
Verition Fund Management Sep 2025 346k $2.0M
Northern Trust Sep 2025 313k $1.8M
Gabelli Funds Sep 2025 310k $1.8M
Gabelli Securities Sep 2025 308k $1.7M
Charles Schwab Investment Management Sep 2025 119k $674k
Raymond James Financial Sep 2025 75k $422k
XTX Topco Sep 2025 65k $369k
Barclays Sep 2025 61k $346k
Susquehanna International Sep 2025 43k $243k
TNB Financial Sep 2025 38k $213k
Jpmorgan Chase & Co Sep 2025 29k $163k
Marshall Wace Sep 2025 27k $152k
Renaissance Technologies Sep 2025 23k $132k
MetLife Investment Advisors Sep 2025 22k $127k
Harvest Management Sep 2025 20k $113k
Virtu Financial Sep 2025 20k $112k
FMR Sep 2025 15k $87k
Gts Securities Sep 2025 15k $83k